Biotransformation of Dairy Waste into ACE-Inhibitory Peptides: A Sustainable Strategy for Blood Pressure Management: Biotransformation of Dairy Waste into ACE-Inhibitory Peptides

Roheela Yasmeen; Amna Sattar; Aneeza Aslam; Hamna Ali

doi:10.54393/fbt.v6i1.215

Authors

Roheela Yasmeen Department of Biology, Lahore Garrison University, Lahore, Pakistan
Amna Sattar Department of Biology, Kinnaird College for Women University, Lahore
Aneeza Aslam Department of Biology, Lahore Garrison University, Lahore, Pakistan
Hamna Ali Department of Biology, Lahore Garrison University, Lahore, Pakistan

DOI:

https://doi.org/10.54393/fbt.v6i1.215

Keywords:

Bioactive Peptides, Fermented Milk, ACE Inhibitors, Biotransformation

Abstract

The bioactive peptides produced by valorization of dairy by-products, specifically whey and casein wastes, are a sustainable approach to the treatment of environmental pollution as well as the health requirements of the population. This review is dedicated to the biotransformation of dairy waste through enzymatic hydrolysis and fermentation with the help of such strains as Lactobacillus helveticus, Lactobacillus brevis, and Pediococcus acidilactici to produce angiotensin-converting enzyme (ACE)-inhibitory peptides, including Val-Pro-Pro and Ile-Pro-Pro. These peptides show good antihypertensive, antioxidant, and anti-inflammatory effects both in vitro and in animals. Independent bioprocessing methods, such as enzyme immobilization and nanoencapsulation, have been used to improve the yield, stability, and bioavailability of peptides. Nevertheless, there are major shortcomings such as inconsistent effects of peptides in clinical trials, lack of human clinical trials, and the inability to scale production, yet keep costs economical. The issue of regulation is also an obstacle to translation because the approval of health claims needs to be based on strong clinical evidence and stable quality, which is not the case at present. This model focuses on waste utilization and sustainability; hence, minimizing the environmental load of dairy effluent and value addition of agro-industrial waste streams. To maximize the potential of dairy waste-based ACE-inhibitory peptides, the main agendas in the future are to put human trials first, standardize production protocols, and provide regulatory directions to attain safety, efficacy, and economic sustainability.

References

Magder S. The Meaning of Blood Pressure. Critical Care. 2018 Oct; 22(1): 1-10. doi: 10.1186/s13054-018- 2171-1.

Parati G, Torlasco C, Pengo M, Bilo G, Ochoa JE. Blood Pressure Variability: Its Relevance for Cardiovascular Homeostasis and Cardiovascular Diseases. Hypertension Research. 2020 Jul; 43(7): 609-620. doi: 10.1038/s41440-020-0421-5.

Schutte AE, Bennett B, Chow CK, Cloud GC, Doyle K, Girdis Z et al. National Hypertension Taskforce of Australia: a Roadmap to Achieve 70% Blood Pressure Control in Australia by 2030. Medical Journal of Australia. 2024 Aug; 221(3): 1-9. doi: 10.5694/mja2.52373.

Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and Management of Blood-Pressure Variability. Nature Reviews Cardiology. 2013 Mar; 10(3): 143-55. doi: 10.1038/nrcardio.2013.1.

Schutte AE, Kollias A, Stergiou GS. Blood Pressure and Its Variability: Classic and Novel Measurement Techniques. Nature Reviews Cardiology. 2022 Oct; 19(10): 643-654. doi: 10.1038/s41569-022-00690-0.

Safarova Z. Blood Pressure Dynamics. An International Multidisciplinary Research Journal. 2021 Jan; 11(1): 2249-7137. doi: 10.5958/2249-7137.2021.00023.9.

Kaur N. Different Treatment Techniques of Dairy Wastewater. Groundwater for Sustainable Development. 2021 Aug; 14. doi: 10.1016/j.gsd.2021.100640.

Rehman S, Hashmi MF, Nelson VL. Blood pressure measurement. 2022 Dec.

Rosei EA, Chiarini G, Rizzoni D. How Important is Blood Pressure Variability? European Heart Journal Supplements. 2020 Jun; 22: 1-6. doi: 10.1093/eurheartj/suaa061.

Australia H. How to lower blood pressure. 2024.

Carey RM, Moran AE, Whelton PK. Treatment of Hypertension: A Review. Jama. 2022 Nov; 328(18): 1849-1861. doi: 10.1001/jama.2022.19590.

Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use? Journal of the American College of Cardiology. 2018 Apr; 71(13): 1474-1482. doi: 10.1016/j.jacc.2018.01.058.

Turner JM and Kodali R. Should Angiotensin-Converting Enzyme Inhibitors Ever Be Used for the Management of Hypertension? Current Cardiology Reports. 2020 Sep; 22(9): 95. doi: 10.1007/s11886-020-01352-8.

Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J et al. Comparative First-Line Effectiveness and Safety of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension. 2021 Sep; 78(3): 591-603. doi: 10.1161/HYPERTENSIONAHA.120.16667.

Yang T, Mei X, Tackie-Yarboi E, Akere MT, Kyoung J, Mell B et al. Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors. Hypertension. 2022 Aug; 79(8): 1591-1601. doi: 10.1161/HYPERTENSIONAHA.121.18711.

Wong MK. Angiotensin Converting Enzyme. In Handbook of Hormones. Academic Press. 2021 Jan: 505-508. doi: 10.1016/B978-0-12-820649-2.00128-5.

Cutrell S, Alhomoud IS, Mehta A, Talasaz AH, Van Tassell B, Dixon DL. Angiotensin-Converting Enzyme -Inhibitors in Hypertension: A Historical Perspective and Current Insights. Current Hypertension Reports. 2023 Sep; 25(9): 243-250.

Guo Y, Jiang X, Xiong B, Zhang T, Zeng X, Wu Z et al. Production and Transepithelial Transportation of Angiotensin-I-Converting Enzyme-Inhibitory Peptides from Whey Protein Hydrolyzed by Immobilized Lactobacillus helveticus Proteinase. Journal of Dairy Science. 2019 Feb; 102(2): 961-75. doi: 10.3168/jds.2018-14899.

Seravalle G and Grassi G. Renin–Angiotensin–Aldosterone System and Blood Pressure Regulation. In Endocrine Hypertension. Academic Press. 2023 Jan: 63-75. doi: 10.1016/B978-0-323-96120-2.00002-9.

Olvera-Rosales LB, Pérez-Escalante E, Castañeda-Ovando A, Contreras-López E, Cruz-Guerrero AE, Regal-López P et al. Angiotensin-Converting Enzyme-inhibitory Activity of Whey Protein Fractions Derived of Fermentation by Lacticaseibacillus rhamnosus (GG) and Streptococcus thermophilus (SY-102). Foods. 2023 Jun; 12(12): 1-13. doi: 10.3390/foods12122416.

Wang S, Han Q, Wei Z, Wang Y, Deng L, Chen M. Formaldehyde Causes an Increase in Blood Pressure by Activating Angiotensin-Converting Enzyme/Angiotensin II Type 1 Receptor axis. Toxicology. 2023 Mar; 486: 153442. doi: 10.1016/j.tox.2023.153442.

Lin K, Zhang LW, Han X, Xin L, Meng ZX, Gong PM et al. Yak Milk Casein as a Potential Precursor of Angiotensin I-Converting Enzyme Inhibitory Peptides Based on in Silico Proteolysis. Food Chemistry. 2018 Jul; 254: 340-347. doi: 10.1016/j.foodchem.2018.02.051.

Faraci FM and Scheer FA. Hypertension: Causes and Consequences of Circadian Rhythms in Blood Pressure. Circulation Research. 2024 Mar; 134(6): 810-832. doi: 10.1161/CIRCRESAHA.124.323515.

Hemming ML and Selkoe DJ. Amyloid β-Protein is Degraded by Cellular Angiotensin-Converting Enzyme and Elevated by an Angiotensin-Converting Enzyme Inhibitor. Journal of Biological Chemistry. 2005 Nov; 280(45): 37644-33650. doi: 10.1074/jbc.M508460200.

Henriksen EJ and Jacob S. Modulation of Metabolic Control by Angiotensin Converting Enzyme Inhibition. Journal of Cellular Physiology. 2003 Jul; 196(1): 171-9. doi: 10.1002/jcp.10294.

Zheng W, Tian E, Liu Z, Zhou C, Yang P, Tian K et al. Small Molecule Angiotensin Converting Enzyme Inhibitors: A Medicinal Chemistry Perspective. Frontiers in Pharmacology. 2022 Nov; 13: 1-25. doi: 10.3389/fphar.2022.968104.

Khurana V and Goswami B. Angiotensin Converting Enzyme. Clinica Chimica Acta. 2022 Jan; 524: 113-22. doi: 10.1016/j.cca.2021.10.029.

Wang Z, Fan H, Bao X, Wu J. Angiotensin-Converting Enzyme 2 Activation Is Not a Common Feature of Angiotensin-Converting Enzyme Inhibitory Peptides. Journal of Agricultural and Food Chemistry. 2023 Jun; 71(23): 8867-8876. doi: 10.1021/acs.jafc.2c04211.

Das M, Pal S, Ghosh A. Angiotensin Converting Enzyme Gene Polymorphism (Insertion/Deletion) and Hypertension in Adult Asian Indians: A Population-Based Study from Calcutta, India. Human Biology. 2008; 80(3): 303-312. doi: 10.1353/hub.2008.a253573.

Acharya KR, Gregory KS, Sturrock ED. Advances in the Structural Basis for Angiotensin-1 Converting Enzyme Inhibitors. Bioscience Reports. 2024 Aug; 44(8): 1-17. doi: 10.1042/BSR20240130.

Bruneau Jr M, Angelopoulos TJ, Gordon P, Moyna N, Visich P, Zoeller R et al. The Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Associates with Habitual Physical Activity Among European American Adults. Molecular Genetics and Genomic Medicine. 2017 Sep; 5(5): 524-30. doi: 10.1002/mgg3.308.

Ryder K, Ali MA, Billakanti J, Carne A. Fundamental Characterisation of Caseins Harvested by Dissolved Air Flotation from Dairy Wastewater and Comparison with Skim Milk Powder. International Dairy Journal. 2018 Mar; 78: 112-121. doi: 10.1016/j.idairyj.2017.11.007.

Argenta AB and Scheer AD. Membrane Separation Processes Applied to Whey: A Review. Food Reviews International. 2020 Jul; 36(5): 499-528. doi: 10.1080/87559129.2019.1649694.

Le D, Brown L, Malik K, Murakami S. Two Opposing Functions of Angiotensin-Converting Enzyme That Link Hypertension, Dementia, And Aging. International Journal of Molecular Sciences. 2021 Dec; 22(24): 1-10. doi: 10.3390/ijms222413178.

Arrighi F, Berrino E, Secci D. Angiotensin-converting enzyme. In Metallo enzymes. Academic Press. 2024 Jan: 239-253. doi: 10.1016/B978-0-12-823974-2.00017-6.

Gregory KS, Cozier GE, Schwager SL, Sturrock ED, Acharya KR. Structural insights into the inhibitory mechanism of angiotensin‐I‐converting enzyme by the lactotripeptides Isoleucine-Proline-Proline and Valine-Proline-Proline. Federation of European Biochemical Societies letters. 2024 Jan; 598(2): 242-251. doi: 10.1002/1873-3468.14768.

Zotta T, Solieri L, Iacumin L, Picozzi C, Gullo M. Valorization of Cheese Whey Using Microbial Fermentations. Applied Microbiology and Biotechnology. 2020 Apr; 104(7): 2749-2764. doi: 10.1007/s00253-020-10408-2.

El‐Aidie SA and Khalifa GS. Innovative applications of whey protein for sustainable dairy industry: Environmental and technological perspectives. A comprehensive review. Comprehensive Reviews in Food Science and Food Safety. 2024 Mar; 23(2): 13319. doi: 10.1111/1541-4337.13319.

Khurana V and Goswami B. Angiotensin Converting Enzyme. Clinica Chemical Acta. 2022 Jan; 524: 113-122. doi: 10.1016/j.cca.2021.10.029.

Karthikeyan V, Venkatesh KR, Arutchelvan V. A Correlation Study on Physico-Chemical Characteristics of Dairy Wastewater. International Journal of Engineering Science and Technology. 2015 Feb; 7(2): 89.

Mizuiri S, Hemmi H, Kumanomidou H, Iwamoto M, Miyagi M, Sakai K et al. Angiotensin-Converting Enzyme I/D Genotype and Renal Angiotensin-Converting Enzyme Gene Expression. Kidney International. 2001 Sep; 60(3): 1124-1130. doi: 10.1046/j.1523-1755.2001.0600031124.x.

Xia Y, Yu J, Xu W, Shuang Q. Purification and Characterization of Angiotensin-I-Converting Enzyme Inhibitory Peptides Isolated from Whey Proteins of Milk Fermented with Lactobacillus plantarum QS670. Journal of Dairy Science. 2020 Jun; 103(6): 4919-4928. doi: 10.3168/jds.2019-17594.

Alvarez-Zaballos S and Martinez-Selles M. Angiotensin-Converting Enzyme and Heart Failure. Frontiers in Bioscience-Landmark. 2023 Jul; 28(7): 150. doi: 10.31083/j.fbl2807150.

Wang W, Liang Q, Zhao B, Chen X, Song X. Functional Peptides from Yak Milk Casein: Biological Activities and Structural Characteristics. International Journal of Molecular Sciences. 2024 Aug; 25(16): 1-19. doi: 10.3390/ijms25169072.

Adams C, Sawh F, Green-Johnson JM, Taggart HJ, Strap JL. Characterization of Casein-Derived Peptide Bioactivity: Differential Effects on Angiotensin-Converting Enzyme Inhibition and Cytokine and Nitric Oxide Production. Journal of Dairy Science. 2020 Jul; 103(7): 5805-5815. doi: 10.3168/jds.2019-17976.